skip to Main Content
[Hankyung] C&R Research “Enter Into The U.S. Clinical Agency Market Within The Year”

[Hankyung] C&R Research “Enter into the U.S. clinical agency market within the year”

Vision for Korea’s ‘No. 1’ CRO company Established a local branch and received project orders Standardize your data with your…

Read more →
[Etoday] C&R Research Expands Performance In The First Half Of The Year… Sales KRW 25.6 Billion

[Etoday] C&R Research expands performance in the first half of the year… Sales KRW 25.6 billion

C&R Research, a clinical trial consignment agency, achieved its highest performance since listing. C&R Research announced on the 14th that…

Read more →
[Hankyung] C&R Research Helps Develop Treatments For Rare Diseases Through ‘external Control Group’

[Hankyung] C&R Research helps develop treatments for rare diseases through ‘external control group’

  C&R Research, Korea's first contract research organization (CRO) company, supports the development of treatments for rare and incurable diseases…

Read more →
[Edaily] C&R Research Selected For Government Task Related To Standardization Of Clinical Trial Data

[Edaily] C&R Research selected for government task related to standardization of clinical trial data

C&R Research (359090) (CEO Moon-Tae Yoon), Korea's largest clinical trial consignment agency, is carrying out 'data standardization and application tasks…

Read more →
[Sedaily] “Re-pursuing The Acquisition Of A Clinical Trial Consignment Agency… Taking The Lead To Decentralized Clinical Trial.”

[Sedaily] “Re-pursuing the acquisition of a Clinical Trial consignment agency… Taking the lead to Decentralized Clinical Trial.”

“For a domestic blockbuster new drug to be created, domestic contract research organizations (CROs) must first secure global-level capabilities. This…

Read more →
Back To Top